Abionyx Pharma SA Capital Reinvestment Ratio

Latest as of December 2022: 0.27x

Abionyx Pharma SA capital reinvestment ratio. Abionyx Pharma SA (ABNX) has a Capital Reinvestment Ratio of 0.27x as of December 2022, meaning it reinvests 0% of its operating cash flow (€214.00K) in capital expenditures (€57.00K). Check how aggressively does Abionyx Pharma SA reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

€214.00K

EUR

Capital Expenditures

€57.00K

EUR

Data as of

Dec 2022

Most recent filing

Abionyx Pharma SA Capital Reinvestment Ratio by Year (None–None)

Abionyx Pharma SA capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of Abionyx Pharma SA.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow